4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression

被引:21
|
作者
Barsoumian, Hampartsoum B.
Yolcu, Esma S. [1 ,2 ]
Shirwan, Haval [1 ,2 ]
机构
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
THERAPEUTIC CANCER VACCINES; MURINE DENDRITIC CELLS; GROWTH-FACTOR-BETA; IFN-GAMMA; MEDIATED APOPTOSIS; IMMUNE-RESPONSES; FOXP3; EXPRESSION; VIVO EXPANSION; CUTTING EDGE; COSTIMULATION;
D O I
10.1371/journal.pone.0153088
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Costimulation with the recombinant SA-4-1BBL agonist of 4-1BB receptor on conventional CD4(+) T cells (Tconvs) overcomes the suppression mediated by naturally occurring CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs). The mechanistic basis of this observation has remained largely unknown. Herein we show that Tconvs, but not Tregs, are the direct target of SA-4-1BBL-mediated evasion of Treg suppression. IL-2 produced by Tconvs in response to 4-1BB signaling is both necessary and sufficient for overcoming Treg suppression. Supernatant from Tconvs stimulated with SA-4-1BBL contains high levels of IL-2 and overcomes Treg suppression in ex vivo Tconv: Treg cocultures. Removal of IL-2 from such supernatant restores Treg suppression and repletion of Tconv: Treg cocultures with exogenous recombinant IL-2 overcomes suppression. This study establishes 4-1BB signaling as a key circuit that regulates physical and functional equilibrium between Tregs and Tconvs with important implications for immunotherapy for indications where a fine balance between Tregs and Teffs plays a decisive role.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells
    Zheng, GX
    Wang, B
    Chen, AS
    JOURNAL OF IMMUNOLOGY, 2004, 173 (04): : 2428 - 2434
  • [22] Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
    Zeiser, Robert
    Leveson-Gower, Dennis B.
    Zambricki, Elizabeth A.
    Kambham, Neeraja
    Beilhack, Andreas
    Loh, John
    Hou, Jing-Zhou
    Negrin, Robert S.
    BLOOD, 2008, 111 (01) : 453 - 462
  • [23] Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation
    Mahic, Milada
    Yaqub, Sheraz
    Bryn, Tone
    Henjum, Karen
    Eide, Dag M.
    Torgersen, Knut M.
    Aandahl, Einar M.
    Tasken, Kjetil
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (05) : 1111 - 1117
  • [24] Functional deficit in CD4+CD25+Foxp3+ regulatory T cells in multiple sclerosis
    Zang, Ying C. Q.
    Hong, Jian
    Skinner, Sheri M.
    Zhang, Jingwu Z.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 195 - 195
  • [25] Frequency and function of CD4+CD25+FOXP3+ regulatory T cells in atopic dermatitis
    Gaspar, Krisztian
    Barath, Sandor
    Nagy, Georgina
    Gyimesi, Edit
    Sipka, Sandor
    Zeher, Margit
    Remenyik, Eva
    Szegedi, Andrea
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S40 - S40
  • [26] CHARACTERISATION OF REGULATORY T CELLS (CD4+CD25+FOXP3+) IN RENAL TRANSPLANT RECIPIENTS
    Xu, Lin Wen
    Bo, Mioduszewski
    Mauro, Sandrin
    Francesco, Ierino
    IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (06): : A5 - A5
  • [27] Induction of alternatively activated macrophages by CD4+CD25+Foxp3+ regulatory T cells
    Jagger, A. L.
    Tiemessen, M. M.
    Taams, L. S.
    IMMUNOLOGY, 2008, 125 : 5 - 5
  • [28] Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
    Long, S. Alice
    Buckner, Jane H.
    JOURNAL OF AUTOIMMUNITY, 2008, 30 (04) : 293 - 302
  • [29] THE COMPARATIVE STUDY FOR EXPANSION OF CD4+CD25+FOXP3+ REGULATORY T CELLS FROM CORD BLOOD CD4+ CELLS USING IL-15 OR IL-2 WITH RAPAMYCIN
    Tanaka, J.
    Sugita, J.
    Asanuma, S.
    Shiratori, S.
    Shigematu, A.
    Fujimoto, K.
    Nishio, M.
    Kondo, T.
    Imamura, M.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S58 - S59
  • [30] CD4+CD25+FOXP3+ malignant T cells in Sezary syndrome are not necessarily functional regulatory T cells
    Wada, David A.
    Pittelkow, Mark R.
    Comfere, Nneka I.
    Gibson, Lawrence E.
    Ansell, Stephen M.
    Wilcox, Ryan A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 485 - 489